101Smart Ltd.

Maximising Day-Case Transurethral Resection of Bladder Tumour (TURBT): The Impact of Dedicated Day Surgery Pathways

Hermione Tsoi

 

Introduction
The Getting It Right First Time (GIRFT) programme recommends increasing day-case TURBT rates due to benefits in cost efficiency, patient flow, and environmental impact. A target day-case rate of 60% is advocated, supported by the British Association of Day Surgery (BADS). We evaluated our current practice and identified opportunities to optimise day-case delivery.

Methods
A retrospective review was conducted of all patients undergoing TURBT between October 2025 and January 2026. Data including patient demographics, tumour size, operative setting, and postoperative outcomes were collected and analysed.

Results
84 TURBTs were performed, with an overall day-case rate of 64.3%. 22 procedures were undertaken in the Day Surgery Unit (DSU) and 62 in main theatres. Day-case rates were significantly higher in the DSU compared to main theatres (90.9% vs 54%). Patients who were managed as inpatients were older (mean 78 vs 71 years), had higher ASA scores (median 3 vs 2), and larger tumours (mean 3.2 cm vs 1.9 cm). Among inpatient cases (n=30), admission was most commonly due to clinical (43.3%) and social (16.7%) factors. Day-case TURBT demonstrated a low 30-day readmission rate (5.5%).

Conclusion
TURBT performed in a DSU setting achieved higher day-case rates. Optimising patient selection, particularly with respect to comorbidity and tumour size, may further increase day-case pathway utilisation and support GIRFT targets.

Authors
Hermione Tsoi, Hadis Reyhani, Mohammed Quraishi, Edward Calleja
Eastbourne District General Hospital, East Sussex, United Kingdom